Logo image of PVLA

PALVELLA THERAPEUTICS INC (PVLA) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:PVLA - US6979471090 - Common Stock

83.97 USD
-3.01 (-3.46%)
Last: 1/27/2026, 8:00:00 PM
83.97 USD
0 (0%)
After Hours: 1/27/2026, 8:00:00 PM
Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to PVLA. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 181.05. This target is 115.61% above the current price.
  • PVLA was analyzed by 21 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about PVLA.
  • In the previous month the buy percentage consensus was at a similar level.
  • PVLA was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
PVLA Historical Analyst RatingsPVLA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -23 -21 -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15 20

Price Target & Forecast

Price Low Median Mean High 83.9791.91194.82181.05220.50 - 9.46% 132.01% 115.61% 162.59%
PVLA Current Analyst RatingPVLA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10
Up and Down Grades
Date Firm Action Rating
2026-01-16 BTIG Reiterate Buy -> Buy
2026-01-07 Mizuho Initiate Outperform
2025-12-16 TD Cowen Maintains Buy -> Buy
2025-12-16 Chardan Capital Maintains Buy -> Buy
2025-12-16 Truist Securities Maintains Buy -> Buy
2025-12-16 Canaccord Genuity Maintains Buy -> Buy
2025-12-15 BTIG Maintains Buy -> Buy
2025-12-15 HC Wainwright & Co. Maintains Buy -> Buy
2025-12-05 Clear Street Initiate Buy
2025-12-05 BTIG Initiate Buy
2025-12-04 Craig-Hallum Initiate Buy
2025-11-24 Stifel Maintains Buy -> Buy
2025-11-19 Raymond James Upgrade Outperform -> Strong Buy
2025-11-13 Chardan Capital Maintains Buy -> Buy
2025-11-13 Canaccord Genuity Maintains Buy -> Buy
2025-11-10 Truist Securities Maintains Buy -> Buy
2025-11-07 Chardan Capital Maintains Buy -> Buy
2025-11-06 TD Cowen Maintains Buy -> Buy
2025-11-06 Cantor Fitzgerald Maintains Overweight -> Overweight
2025-11-06 HC Wainwright & Co. Maintains Buy -> Buy
2025-10-09 Canaccord Genuity Maintains Buy -> Buy
2025-10-02 Truist Securities Maintains Buy -> Buy
2025-09-26 Chardan Capital Maintains Buy -> Buy
2025-09-25 HC Wainwright & Co. Maintains Buy -> Buy
2025-09-24 Stifel Maintains Buy -> Buy
2025-09-09 Oppenheimer Initiate Outperform
2025-08-19 Canaccord Genuity Maintains Buy -> Buy
2025-08-15 Chardan Capital Maintains Buy -> Buy
2025-08-15 HC Wainwright & Co. Maintains Buy -> Buy
2025-08-06 Raymond James Initiate Outperform

PALVELLA THERAPEUTICS INC / PVLA FAQ

What is the average price target for PALVELLA THERAPEUTICS INC (PVLA) stock?

21 analysts have analysed PVLA and the average price target is 181.05 USD. This implies a price increase of 115.61% is expected in the next year compared to the current price of 83.97.


Can you provide the consensus rating for PALVELLA THERAPEUTICS INC stock?

The consensus rating for PALVELLA THERAPEUTICS INC (PVLA) is 84.7619 / 100 . This indicates that analysts generally have a positive outlook on the stock.